Novartis halts distribution of its Zantac versions impurities

8

PHOTO FILE: Logo of Swiss drugmaker Novartis, Switzerland, March 29, 2018. t

(Reuters) – Novartis AG´s (NOVN.SZantac in all its markets, including the United States and Canada, after contaminants were found in the heartburn drug.

The Swiss drugmaker's steps follow the investigation by U.S. Tuesday, Tuesday, October 9, 2010.

Health Canada said it has been requested.

Sanofi SA’s (SASY.PA) Zantac available for over-the-counter sale in Canada

A distribution is not available.

Neither the U.S. Food and Drug Administration t

Is was Nov its statement statement statement statement statement statement statement will statement will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will will

In New York; Editing by Maju Samuel

Our Standards:The Thomson Reuters Trust Principles.

(tagsToTranslate) US (t) NOVARTIS (t) HEARTBURN (t) Americas (t) Heartburn (t) Switzerland (t) Company News (t) Content produced in Bangalore (t) France (t) Gastric Disorders (t) General News (t) Europe (t) Pharmaceuticals and Medical Research (TRBC) (t) Healthcare (TRBC) (t) Canada

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.